Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
NAVAN logo — Transforming Cell Therapy Engineering

NAVAN

Transforming Cell Therapy Engineering

Founded 2017 United States San Carlos, United States 7 employees Seed Total: $750.00K Biotechnology, Health Care

General Information

Company Name NAVAN
Founded Year 2017
Location United States San Carlos, United States
Employees 7
Industries Biotechnology, Health Care
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with NAVAN. To contact NAVAN, visit navanbio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does NAVAN compare?

A PDF of NAVAN and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting NAVAN soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About NAVAN

NAVAN Technologies, Inc. is a pioneering biotechnology company with the slogan "Transforming Cell Therapy Engineering". Founded in 2016 and based in the United States, NAVAN is focused on commercializing a groundbreaking non-viral delivery platform that significantly expedites genetic engineering of human stem & primary cells. The company's patented NanoStraw technology enables direct intracellular access into challenging-to-transfect stem & primary human cells for efficient delivery of various cargoes. By leveraging a physical, non-perturbative delivery mechanism, NAVAN eliminates the time, cost, and technical challenges associated with viral-based cell manufacturing, resulting in a streamlined operational process. The company secured a Seed Round investment on 25 April 2019 from notable investors including Amgen Ventures, Hemi Ventures, and HTGF | High-Tech Gruenderfonds. For more information on NAVAN, please visit www.navanbio.com.

Business keywords: nanotechnology, pre-clinical stage, material delivery, cellular technology, transfection, cellular connection, drug delivery systems, biomedical technology

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round Undisclosed 3
Amgen Ventures Hemi Ventures
Amgen Ventures, Hemi Ventures +1
25 Apr 2019
Grant $750.00K 1
National Science Foundation
National Science Foundation
08 Mar 2018

NAVAN Alternatives & Competitors

View All Alternatives
NAVAN vs
ARIZ Precision Medicine
ARIZ Precision Medicine United States

Targeting Cancer at the Root Cause

Seed
2 employees
Biotechnology, Health Care
NAVAN vs
OnQuality Pharmaceuticals Ltd.
OnQuality Pharmaceuticals Ltd. China

developing innovative drugs and drug delivery systems that improve the quality of life of oncology p...

Series A
7 employees
Biopharma, Biotechnology
NAVAN vs
LUCA Science Inc.
LUCA Science Inc. Japan

Enabling functional mitochondria as therapeutic agents.

Series B
12 employees
Biotechnology, Health Care
View all alternatives

FAQ About NAVAN

Transforming Cell Therapy Engineering
NAVAN was founded in 2017.
NAVAN is headquartered in San Carlos, United States.
NAVAN operates in Biotechnology and Health Care. Its work centres on nanotechnology, pre-clinical stage, material delivery and cellular technology.
NAVAN has approximately 7 employees.
NAVAN has completed 2 funding rounds, raising a total of $750.00K. The latest funding stage is Seed.
Top alternatives and competitors to NAVAN include ARIZ Precision Medicine, OnQuality Pharmaceuticals Ltd., LUCA Science Inc., Pulse Therapeutics, Inc., Sentien Biotechnologies, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
NAVAN and ARIZ Precision Medicine are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for NAVAN, https://bouncewatch.com/company/navan-technologies, updated 24 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes